Journal of Dermatological Treatment 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis
Conclusions: This case suggests, that not only a dual IL-4-/IL-13-blockade, but also a selective IL-13-inhibition is able to skew immune responses toward IL-17 cytokine pathway-related disease. However, no clinical scores exist to predict the development of paradoxical psoriasis in patients with AD during therapy with biologics.PMID:37705378 | DOI:10.1080/09546634.2023.2258240 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - September 14, 2023 Category: Dermatology Authors: Galina Balakirski Sven-Niklas Burmann Silke C Hofmann Alexander Kreuter Source Type: research
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa
J Dermatolog Treat. 2023 Dec;34(1):2256905. doi: 10.1080/09546634.2023.2256905.NO ABSTRACTPMID:37705359 | DOI:10.1080/09546634.2023.2256905 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - September 14, 2023 Category: Dermatology Authors: Carlo Alberto Vignoli Luigi Gargiulo Federica Sanna Alessandra Narcisi Antonio Costanzo Source Type: research
Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis
Conclusions: This case suggests, that not only a dual IL-4-/IL-13-blockade, but also a selective IL-13-inhibition is able to skew immune responses toward IL-17 cytokine pathway-related disease. However, no clinical scores exist to predict the development of paradoxical psoriasis in patients with AD during therapy with biologics.PMID:37705378 | DOI:10.1080/09546634.2023.2258240 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - September 14, 2023 Category: Dermatology Authors: Galina Balakirski Sven-Niklas Burmann Silke C Hofmann Alexander Kreuter Source Type: research
Adalimumab-induced paradoxical pustular psoriasis and alopecia successfully treated with ixekizumab in a patient affected by hidradenitis suppurativa
J Dermatolog Treat. 2023 Dec;34(1):2256905. doi: 10.1080/09546634.2023.2256905.NO ABSTRACTPMID:37705359 | DOI:10.1080/09546634.2023.2256905 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - September 14, 2023 Category: Dermatology Authors: Carlo Alberto Vignoli Luigi Gargiulo Federica Sanna Alessandra Narcisi Antonio Costanzo Source Type: research
Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis
Conclusions: This case suggests, that not only a dual IL-4-/IL-13-blockade, but also a selective IL-13-inhibition is able to skew immune responses toward IL-17 cytokine pathway-related disease. However, no clinical scores exist to predict the development of paradoxical psoriasis in patients with AD during therapy with biologics.PMID:37705378 | DOI:10.1080/09546634.2023.2258240 (Source: Journal of Dermatological Treatment)
Source: Journal of Dermatological Treatment - September 14, 2023 Category: Dermatology Authors: Galina Balakirski Sven-Niklas Burmann Silke C Hofmann Alexander Kreuter Source Type: research
